Hilco is pleased to offer for sale the business and assets of an innovative company specialising in advanced adaptive seating solutions for wheelchair users (the “Company”), providing groundbreaking products that enhance postural support, comfort, and independence. The Company has an established reputation in the assistive technology sector and has garnered significant attention for its cutting-edge products and collaborative partnerships with healthcare professionals and distributors. The proprietary air cell technology also has potential applications in other seating systems beyond wheelchairs, broadening its market potential for office chairs, transportation and more.
Company Highlights
Advanced Technology: The Company has developed smart air cell technology integrated into its seating systems, offering dynamic, responsive support that adjusts to user movements. This cutting-edge approach improves user comfort, minimises the risk of pressure-related injuries, and meets rigorous health and safety standards as CE-marked Class 1 Medical Devices.
Proven Track Record & Key Partnerships: The Company has collaborated with healthcare professionals, therapists, and wheelchair users to co-develop solutions, ensuring their products meet real-world needs and deliver exceptional outcomes. The Company has also secured a four-year NHS supply chain framework contract for modular seating, establishing it as a trusted supplier in the UK healthcare sector.
Established Market Presence: Renowned within the assistive technology sector, the Company has a reputation for excellence, serving both paediatric and adult wheelchair users with its range of adaptable and cost-effective solutions. The Company also demonstrated the viability of the technology through a pilot study with ten wheelchair users and a soft launch trial with 62 families, showcasing the effectiveness and widespread acceptance of its innovative products.
User-Centric Solutions: Products like the fully responsive postural management system and smart cushion enhance user independence with features controlled via an intuitive mobile app and remote clinical monitoring capabilities.
Award-Winning Innovation: Acknowledged for its contributions to inclusive technology, the Company has received notable recognition for its pioneering efforts, reinforcing its position as a leader in the assistive technology sector.
Available Assets
Patented Technology: The Company holds exclusive patents covering its advanced adaptive seating systems, which incorporate modular designs, responsive air cell technology, and wireless communication capabilities, providing a strong competitive edge.
Software Portfolio: A proprietary mobile app and cloud-based clinical portal enable personalised user settings and remote monitoring, providing additional revenue opportunities through data-driven healthcare applications.
Intellectual Property: Comprehensive IP portfolio, including trade marks, unregistered designs, domain names, website content, social media accounts and customer and supplier data.
Customer and Market Relationships: Established partnerships with distributors, therapists, and clinics across the UK and Ireland, offering a springboard for international expansion.
Optimised Manufacturing Infrastructure: Streamlined manufacturing systems and rigorous quality control measures are in place, enabling efficient scaling and ensuring reliable delivery of high-quality products.
This acquisition presents an opportunity to enter or expand within the assistive technology sector, leveraging the Company’s advanced solutions, strong market reputation, and established network of industry partnerships.
Sales Process & Further Information
Please register your interest and direct any questions in the first instance to Sophie Felstead, +44 (0) 7394 802845, [email protected] and Alexander Muir, +44 (0) 7593 562917, [email protected] of Hilco, who will be able to provide access to further information on the signing of a confidentiality agreement and answer any questions you have at this stage. Bids are to be directed in writing to Hilco. A buyer’s premium of 10% of the sale price is payable by the winning bidder. Terms and conditions related to the sale can be provided on request.
